Your browser doesn't support javascript.
loading
Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma.
Bolomsky, Arnold; Schreder, Martin; Hübl, Wolfgang; Zojer, Niklas; Hilbe, Wolfgang; Ludwig, Heinz.
Affiliation
  • Bolomsky A; a Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology , Wilhelminen Hospital , Vienna , Austria ;
  • Schreder M; a Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology , Wilhelminen Hospital , Vienna , Austria ;
  • Hübl W; b Department of Laboratory Medicine , Wilhelminen Hospital , Vienna , Austria.
  • Zojer N; a Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology , Wilhelminen Hospital , Vienna , Austria ;
  • Hilbe W; a Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology , Wilhelminen Hospital , Vienna , Austria ;
  • Ludwig H; a Wilhelminen Cancer Research Institute, Department of Medicine I, Center for Oncology and Hematology , Wilhelminen Hospital , Vienna , Austria ;
Leuk Lymphoma ; 57(11): 2516-25, 2016 11.
Article in En | MEDLINE | ID: mdl-26999330

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemokine CXCL9 / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Chemokine CXCL9 / Multiple Myeloma Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2016 Document type: Article Country of publication: United States